No Data
No Data
Zura Bio (ZURA) Gets a Buy From Guggenheim
Chardan Capital Maintains Zura Bio(ZURA.US) With Buy Rating, Cuts Target Price to $10
Zura Bio Reports FY Results
Zura Bio Shares Are Trading Lower After the Company Reported FY24 Financial Results and Multiple Firms Cut Their Respective Price Targets on the Stock.
Express News | Zura Bio Shares Are Trading Lower After the Company Reported FY24 Financial Results and Multiple Firms Cut Their Respective Price Targets on the Stock
Leerink Partners Maintains Zura Bio(ZURA.US) With Buy Rating, Announces Target Price $12